WaferGen Bio-systems Inc (WGBS)

5.66
0.07 1.20
NASDAQ : Health Care
Prev Close 5.73
Open 5.74
Day Low/High 5.67 / 5.80
52 Wk Low/High 0.46 / 3.47
Volume 20.97K
Avg Volume 56.00K
Exchange NASDAQ
Shares Outstanding 3.79M
Market Cap 21.01M
EPS -12.90
Div & Yield N.A. (N.A)

Latest News

WaferGen Bio-systems Announces Adjournment Of Special Meeting Of Stockholders

WaferGen Bio-systems Announces Adjournment Of Special Meeting Of Stockholders

Stockholders are urged to vote "FOR" the proposed merger at or prior to the rescheduled special meeting on November 15, 2016

ISS And Glass Lewis Proxy Advisory Services Recommend WaferGen Bio-systems Stockholders Vote

ISS And Glass Lewis Proxy Advisory Services Recommend WaferGen Bio-systems Stockholders Vote "FOR" Proposed Merger With Takara Bio

WaferGen Urges Stockholders to Vote "FOR" the Proposed Merger

WaferGen (WGBS) Stock Gains Ahead of Tuesday's Q2 Results

WaferGen (WGBS) Stock Gains Ahead of Tuesday's Q2 Results

WaferGen (WGBS) is expected to report its 2016 second quarter results after Tuesday's closing bell.

WaferGen Bio-systems And Takara Bio Inc. Announce Exclusive Distribution Agreement For Japan

WaferGen Bio-systems And Takara Bio Inc. Announce Exclusive Distribution Agreement For Japan

Agreement Expands Access to WaferGen's Single-Cell and Clinical Research Products in the Asia-Pacific Region

WaferGen Bio-systems And Takara Bio Inc. Announce Merger Agreement

WaferGen Bio-systems And Takara Bio Inc. Announce Merger Agreement

Transaction scheduled to close following completion of the 2016 fiscal year

WaferGen Bio-systems Announces Placement Of ICELL8™ Single-Cell System At Neural Stem Cell Institute

WaferGen Bio-systems Announces Placement Of ICELL8™ Single-Cell System At Neural Stem Cell Institute

ICELL8™ Single-Cell System to Enable Innovative Stem Cell and Regenerative Medicine Research

WaferGen Announces Key Findings From Collaborators Utilizing Company's ICELL8™ Single-Cell System At AGBT 2016 General Meeting

WaferGen Announces Key Findings From Collaborators Utilizing Company's ICELL8™ Single-Cell System At AGBT 2016 General Meeting

Results From Genentech, Karolinska Institutet, National Jewish Health, and MD Anderson Cancer Center Highlight ICELL8™ Single-Cell System Performance

WaferGen Announces ICELL8™ Single-Cell System Collaborators To Present Key Results At AGBT 2016 General Meeting

WaferGen Announces ICELL8™ Single-Cell System Collaborators To Present Key Results At AGBT 2016 General Meeting

Researchers From Genentech, Karolinska Institutet and National Jewish Health to Present Results Using WaferGen's ICELL8™ Single-Cell System

WaferGen Bio-systems Announces Collaboration With BloodCenter Of Wisconsin For High Throughput Molecular Blood Typing

WaferGen Bio-systems Announces Collaboration With BloodCenter Of Wisconsin For High Throughput Molecular Blood Typing

Supply Agreement Enables Identification of Rare Blood Donors Using WaferGen's Proprietary SmartChip™ Technology

WaferGen Bio-systems And Luxembourg Institute Of Health Collaborate To Support Introduction Of ICELL8™ Single-Cell System To European Medical Researchers

WaferGen Bio-systems And Luxembourg Institute Of Health Collaborate To Support Introduction Of ICELL8™ Single-Cell System To European Medical Researchers

Agreement Expands WaferGen's European Customer Demonstration Laboratory Capabilities to include the ICELL8 Single-Cell System

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of breaking out and trading higher from current levels.

WaferGen Bio-systems Announces Supply Agreement With Reprogenetics For Next-Generation Sequencing (NGS) Automated Solutions Focused On In-Vitro Fertilization (IVF)

WaferGen Bio-systems Announces Supply Agreement With Reprogenetics For Next-Generation Sequencing (NGS) Automated Solutions Focused On In-Vitro Fertilization (IVF)

Supply Agreement Enables Automation of NGS Library Preparation for Preimplantation Genetic Screening Technology Used in IVF

WaferGen Bio-systems Announces Successful Completion Of $17.25 Million Public Offering

WaferGen Bio-systems Announces Successful Completion Of $17.25 Million Public Offering

Proceeds to be Used Primarily for Research and Development Initiatives and ICELL8(TM) Single-Cell System Commercialization Activities

WaferGen Bio-systems (WGBS) Stock Falls After Pricing Public Offering

WaferGen Bio-systems (WGBS) Stock Falls After Pricing Public Offering

WaferGen Bio-systems (WGBS) shares are lower after pricing the 3.92 million shares of common stock in its public offering.

Wafergen Bio-systems (WGBS) Weak On High Volume Today

Wafergen Bio-systems (WGBS) Weak On High Volume Today

Trade-Ideas LLC identified Wafergen Bio-systems (WGBS) as a weak on high relative volume candidate

WaferGen Bio-systems (WGBS) Stock Spikes on High Revenue Guidance

WaferGen Bio-systems (WGBS) Stock Spikes on High Revenue Guidance

WaferGen Bio-systems (WGBS) shares are higher after the company announced it expects record revenue in the third quarter.